STAT+: Glenmark to pay $29.6 million to settle price-fixing allegations in long-running battle with states
Glenmark Pharmaceuticals agreed to pay $29.6 million to settle price-fixing allegations in a long-running battle with dozens of states.
Read the full article
Comments
Sign in to join the conversation.
No comments yet. Be the first.